Botox Treatment in Boston MA

Botox Treatment in Boston MA

Botox treatment in Boston MA is an FDA-approved injectable treatment that can temporarily reduce the appearance of facial lines and wrinkles. The medication is injected directly into the skin and works by blocking nerve signals that control muscle movement in the face. This reduces contractions that cause wrinkling of the skin. Results typically last about four months.

In addition to smoothing fine lines and wrinkles, Botox treatment in Boston MA has also been used to treat medical conditions such as chronic migraines and excessive sweating. If you want to treat your wrinkles with Botox, it’s important to find a skilled specialist who is properly trained to treat patients using this medication. At our practice, Dr. Gutierres has received extensive training in the administration of Botox and dermal fillers. 

Is Botox Treatment in Boston MA right for me?

If you’re considering Botox treatment in Boston MA we recommend consulting with a specialist to discuss your needs and whether you’re a good candidate for treatment. Like fillers and other options we offer at our clinic, this is a cosmetic procedure that not everyone may benefit from. Schedule a consultation with us to learn more about what’s right for you!

Does Botox Treatment in Boston MA last forever?

No, Botox treatments typically last about 3 to 4 months. After that period of time has passed, you’ll need to return to our office for follow-up treatments, and further injections will be administered as necessary. The good news is that you will gradually require less product each time you come in for treatments. The time between visits will only increase as the product wears off and you’re able to retain a more natural smile. There’s no risk of overdose with Botox. As a cosmetic treatment, it is completely safe. 

If you have questions about Botox Treatment in Boston MA, call Dr. Bruno Gutierres now! We look forward to helping you achieve your cosmetic goals with our range of advanced aesthetic services.